30 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35197312 | CYP2C19 plays a major role in the hepatic N-oxidation of cotinine. | 2022 Feb 23 | 1 |
2 | 34520119 | Nicotine metabolism and its association with CYP2A6 genotype among Indigenous people in Alaska who smoke. | 2021 Nov | 1 |
3 | 30815984 | Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. | 2020 Jan | 1 |
4 | 30381441 | Nicotine-N'-Oxidation by Flavin Monooxygenase Enzymes. | 2019 Feb | 1 |
5 | 29158210 | Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways. | 2018 Feb | 1 |
6 | 28181923 | Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer. | 2017 May | 1 |
7 | 29048184 | Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. | 2017 Oct | 1 |
8 | 26818358 | Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity. | 2016 Mar | 1 |
9 | 27488534 | Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. | 2016 Oct 1 | 1 |
10 | 26014804 | Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation. | 2015 Aug | 2 |
11 | 26132489 | Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. | 2015 | 1 |
12 | 23674838 | Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes. | 2013 Nov | 2 |
13 | 23936477 | Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake. | 2013 | 3 |
14 | 22552800 | Reproducibility of the nicotine metabolite ratio in cigarette smokers. | 2012 Jul | 1 |
15 | 22569203 | CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. | 2012 Jun | 1 |
16 | 22938167 | Nicotine intake and smoking topography in smokers with bipolar disorder. | 2012 Sep | 2 |
17 | 20717551 | Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population. | 2010 Jul | 4 |
18 | 20719908 | Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. | 2010 Oct | 1 |
19 | 19959692 | Utility and relationships of biomarkers of smoking in African-American light smokers. | 2009 Dec | 2 |
20 | 18216723 | A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. | 2008 Jan | 4 |
21 | 18559554 | Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. | 2008 Jun | 2 |
22 | 19029401 | Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. | 2008 Dec | 1 |
23 | 16402128 | Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. | 2006 Apr | 1 |
24 | 16765148 | Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. | 2006 Jun | 2 |
25 | 17035386 | CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. | 2006 Oct | 6 |
26 | 16141602 | Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. | 2005 Aug | 1 |
27 | 16372023 | Ethnic differences in nicotine metabolic rate among New Zealanders. | 2005 Dec 16 | 1 |
28 | 12504349 | Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. | 2003 Feb 1 | 1 |
29 | 14577978 | Nicotine metabolite ratio as a predictor of cigarette consumption. | 2003 Oct | 3 |
30 | 12024803 | Effects of whole deletion of CYP2A6 on nicotine metabolism in humans. | 2002 May | 2 |